查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1301134

伽瑪刀市場規模、份額和趨勢分析報告：按適應症、按地區、細分市場趨勢，2023-2030 年

Gamma Knife Market Size, Share & Trends Analysis Report By Indication (Malignant Tumors, Benign Tumors, Vascular Disorders, Functional Disorders, Ocular Diseases), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 105 Pages | 商品交期: 2-10個工作天內

價格

伽瑪刀市場增長和趨勢

根據 Grand View Research, Inc 的最新報告，到 2030 年，全球伽馬刀市場預計將達到 6.264 億美元。

預計 2023 年至 2030 年復合年增長率為 5.0%。 癌症、腦腫瘤和其他神經系統疾病患病率的上升、手術中心越來越多地採用這些儀器、對微創手術 (MIS) 的日益青睞以及儀器技術的進步正在推動市場。這是推動市場發展的幾個因素之一。預計

伽瑪刀療法用於治療各種腦部和神經系統疾病，例如腦腫瘤、腦轉移、癲癇和動靜脈畸形。 由於具有安全性、微觀精度、術後並發症少、切口少等多種優點，手術中心的需求正在不斷增加。

技術進步提高了手術的準確性。 例如，Leksell 伽瑪刀型號 U、B、C/4C 和 Perfexion 升級為 Icon，提高了手術的微觀精度，並鼓勵手術中心採用該設備。 根據 Elekta AB 發布的一份報告，每年約有 70,000 名患者接受伽瑪刀手術。 由於目標疾病患病率不斷上升以及對 MIS 的偏好不斷增加，預計這一數字在預測期內還會增加。

此外，與開放手術相比，對 MIS 的需求不斷增長也是推動這種治療方法越來越多采用的主要因素之一。 伽瑪刀治療比開放手術創傷更小，恢復也更快。 減少住院時間可確保經濟可行性並降低醫療費用。 更少的切口和更少的術後並發症是推動微創手術需求的主要因素。

伽瑪刀市場報告亮點

  • 到 2022 年，惡性腫瘤將成為最大的適應症，功能障礙細分市場將在預測期內增長最快
  • 由於癌症患病率上升、醫療基礎設施發展以及新興經濟體經濟快速發展，亞太地區將在 2022 年佔據最大收入份額
  • 伽瑪刀是該公司的專利產品，因此該市場上只有 Elekta AB 運營。

內容

第一章調查方法及範圍

  • 市場細分和範圍
    • 產品
    • 針長
    • 治療
    • 區域範圍
    • 估計/預測時間表
  • 調查方法
  • 信息獲取
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
    • 初步調查的詳細信息
  • 信息或數據分析
    • 數據分析模型
  • 市場形成和驗證
  • 型號詳細信息
    • 產品流分析（模型 1）
    • 批量價格分析（模型 2）
  • 輔助信息列表
  • 主要信息列表
  • 目的

第 2 章執行摘要

  • 市場概況
  • 片段快照
  • 衝突快照

第 3 章伽瑪刀市場變量、趨勢和範圍

  • 市場體系展望
    • 母公司市場前景
    • 相關/補充市場前景
  • 採用和增長前景圖
  • 市場動態
    • 市場驅動因素分析
    • 市場製約因素分析
  • 伽瑪刀市場分析工具
    • 行業分析-波特分析
    • PESTEL 分析
    • 主要交易和戰略聯盟分析
    • 市場進入策略

第四章伽馬刀市場：估算和趨勢分析

  • 2022 年和 2030 年適應症市場份額
  • 細分儀表板
  • 按適應症劃分的全球伽瑪刀市場展望
  • 2018-2030 年以下市場規模、預測和趨勢分析
    • 惡性腫瘤
    • 良性腫瘤
    • 血管疾病
    • 功能障礙
    • 眼科

第五章伽馬刀市場：區域估算和趨勢分析

  • 2022 年和 2030 年區域市場份額分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2022 年區域市場份額和主要參與者
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 2018-2030年市場應用、預測及趨勢分析
  • 北美
    • 2018-2030 年市場預估和預測（收入）
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 印度
    • 中國
    • 韓國
    • 澳大利亞
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 科威特

第 6 章競爭格局

  • 主要市場進入者的最新趨勢和影響分析
  • 公司/競爭對手分類
    • 創新者
  • 供應商情況
    • 主要經銷商和渠道合作夥伴名單
    • 主要客戶
    • 2022 年主要參與者的市場份額分析
    • Elekta AB
    • Huiheng Medical, Inc.
    • MASEP Medical Science Technology Development（Shenzhen）Co., Ltd.
    • Akesis Inc.
Product Code: GVR-1-68038-581-6

Gamma Knife Market Growth & Trends

The global gamma knife market size is expected to reach USD 626.4 million by 2030, according to a new report by Grand View Research, Inc. It is expected to grow at a CAGR of 5.0% from 2023 to 2030. The increasing prevalence of cancer, brain tumors, and other neurological diseases, rising adoption of these instruments in surgery centers, growing preference for Minimally Invasive Surgeries (MIS), and technological advancements in the device are among few factors expected to drive the market.

Gamma knife therapy is used for the treatment of various brain and neurological disorders such as brain tumors, brain metastases, epilepsy, and arteriovenous malformations. Demand for these instruments in surgery centers is growing due to their various advantages such as safety, micro-precision, lack of postsurgical complications, and lack of incisions.

Technological advancements have improved precision in surgery. For instance, the up-gradation of Leksell Gamma Knife models U, B, C/4C, and Perfexion to Icon provided micro-precision in surgery and boosted the adoption of this device in surgery centers. According to reports published by Elekta AB, approximately 70,000 patients undergo gamma knife surgery each year. This number is expected to increase over the forecast period owing to the rising prevalence of target diseases and increasing preference for MIS.

In addition, the growing demand for MIS over open surgeries is one of the key factors responsible for increasing the adoption of this therapy. Gamma knife treatment procedure results in fewer traumas and faster recovery as compared to open surgeries. It helps reduce hospital stays, thus ensuring economic viability and reduction in medical expenses. Lack of incisions and post-surgical complications are key factors responsible for boosting the demand for minimally invasive surgeries.

Gamma Knife Market Report Highlights

  • Malignant tumors emerged as the largest indication segment in 2022. The functional disorders segment is anticipated to witness the fastest growth over the forecast period
  • The Asia Pacific held the largest revenue share in 2022 owing to the rising incidence of cancer, developments in healthcare infrastructure, and rapid economic development across major emerging economies
  • Elekta AB is the only player operating in this market since Gamma Knife is a patent-protected trademark product of the company

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Needle Length
    • 1.1.3. Therapy
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Snapshot

Chapter 3. Gamma knife Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Gamma knife Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
    • 3.4.3. Major Deals & Strategic Alliances Analysis
    • 3.4.4. Market Entry Strategies

Chapter 4. Gamma Knife Market: Indication Estimates & Trend Analysis

  • 4.1. Indication Market Share, 2022 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Gamma Knife Market by Indication Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Malignant Tumors
      • 4.4.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.2. Benign Tumors
      • 4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.3. Vascular Disorders
      • 4.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.4. Functional Disorders
      • 4.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.5. Ocular
      • 4.4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Gamma Knife Market: Regional Estimates & Trend Analysis

  • 5.1. Regional market share analysis, 2022 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Global Regional Market Snapshot
  • 5.4. Regional Market Share and Leading Players, 2022
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East and Africa
  • 5.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030
  • 5.6. North America
    • 5.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. U.S.
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory framework
      • 5.6.2.4. Reimbursement scenario
      • 5.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
    • 5.6.3. Canada
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory framework
      • 5.6.3.4. Reimbursement scenario
      • 5.6.3.5. Canada market estimates and forecasts, 2018 - 2030
  • 5.7. Europe
    • 5.7.1. UK
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Competitive Scenario
      • 5.7.1.3. Regulatory framework
      • 5.7.1.4. Reimbursement scenario
      • 5.7.1.5. UK market estimates and forecasts, 2018 - 2030
    • 5.7.2. Germany
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Competitive Scenario
      • 5.7.2.3. Regulatory framework
      • 5.7.2.4. Reimbursement scenario
      • 5.7.2.5. Germany market estimates and forecasts, 2018 - 2030
    • 5.7.3. France
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Competitive Scenario
      • 5.7.3.3. Regulatory framework
      • 5.7.3.4. Reimbursement scenario
      • 5.7.3.5. France market estimates and forecasts, 2018 - 2030
    • 5.7.4. Italy
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Competitive Scenario
      • 5.7.4.3. Regulatory framework
      • 5.7.4.4. Reimbursement scenario
      • 5.7.4.5. Italy market estimates and forecasts, 2018 - 2030
    • 5.7.5. Spain
      • 5.7.5.1. Key country dynamics
      • 5.7.5.2. Competitive Scenario
      • 5.7.5.3. Regulatory framework
      • 5.7.5.4. Reimbursement scenario
      • 5.7.5.5. Spain market estimates and forecasts, 2018 - 2030
    • 5.7.6. Denmark
      • 5.7.6.1. Key country dynamics
      • 5.7.6.2. Competitive Scenario
      • 5.7.6.3. Regulatory framework
      • 5.7.6.4. Reimbursement scenario
      • 5.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
    • 5.7.7. Sweden
      • 5.7.7.1. Key country dynamics
      • 5.7.7.2. Competitive Scenario
      • 5.7.7.3. Regulatory framework
      • 5.7.7.4. Reimbursement scenario
      • 5.7.7.5. Market estimates and forecasts, 2018 - 2030
    • 5.7.8. Norway
      • 5.7.8.1. Key country dynamics
      • 5.7.8.2. Competitive Scenario
      • 5.7.8.3. Regulatory framework
      • 5.7.8.4. Reimbursement scenario
      • 5.7.8.5. Norway market estimates and forecasts, 2018 - 2030
  • 5.8. Asia Pacific
    • 5.8.1. Japan
      • 5.8.1.1. Key country dynamics
      • 5.8.1.2. Competitive Scenario
      • 5.8.1.3. Regulatory framework
      • 5.8.1.4. Reimbursement scenario
      • 5.8.1.5. Japan market estimates and forecasts, 2018 - 2030
    • 5.8.2. India
      • 5.8.2.1. Key country dynamics
      • 5.8.2.2. Competitive Scenario
      • 5.8.2.3. Regulatory framework
      • 5.8.2.4. Reimbursement scenario
      • 5.8.2.5. India market estimates and forecasts, 2018 - 2030
    • 5.8.3. China
      • 5.8.3.1. Key country dynamics
      • 5.8.3.2. Competitive Scenario
      • 5.8.3.3. Regulatory framework
      • 5.8.3.4. Reimbursement scenario
      • 5.8.3.5. China market estimates and forecasts, 2018 - 2030
    • 5.8.4. South Korea
      • 5.8.4.1. Key country dynamics
      • 5.8.4.2. Competitive Scenario
      • 5.8.4.3. Regulatory framework
      • 5.8.4.4. Reimbursement scenario
      • 5.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
    • 5.8.5. Australia
      • 5.8.5.1. Key country dynamics
      • 5.8.5.2. Competitive Scenario
      • 5.8.5.3. Regulatory framework
      • 5.8.5.4. Reimbursement scenario
      • 5.8.5.5. Australia market estimates and forecasts, 2018 - 2030
    • 5.8.6. Thailand
      • 5.8.6.1. Key country dynamics
      • 5.8.6.2. Competitive Scenario
      • 5.8.6.3. Regulatory framework
      • 5.8.6.4. Reimbursement scenario
      • 5.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
  • 5.9. Latin America
    • 5.9.1. Brazil
      • 5.9.1.1. Key country dynamics
      • 5.9.1.2. Competitive Scenario
      • 5.9.1.3. Regulatory framework
      • 5.9.1.4. Reimbursement scenario
      • 5.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
    • 5.9.2. Mexico
      • 5.9.2.1. Key country dynamics
      • 5.9.2.2. Competitive Scenario
      • 5.9.2.3. Regulatory framework
      • 5.9.2.4. Reimbursement scenario
      • 5.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
    • 5.9.3. Argentina
      • 5.9.3.1. Key country dynamics
      • 5.9.3.2. Competitive Scenario
      • 5.9.3.3. Regulatory framework
      • 5.9.3.4. Reimbursement scenario
      • 5.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
  • 5.10. MEA
    • 5.10.1. South Africa
      • 5.10.1.1. Key country dynamics
      • 5.10.1.2. Competitive Scenario
      • 5.10.1.3. Regulatory framework
      • 5.10.1.4. Reimbursement scenario
      • 5.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
    • 5.10.2. Saudi Arabia
      • 5.10.2.1. Key country dynamics
      • 5.10.2.2. Competitive Scenario
      • 5.10.2.3. Regulatory framework
      • 5.10.2.4. Reimbursement scenario
      • 5.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
    • 5.10.3. UAE
      • 5.10.3.1. Key country dynamics
      • 5.10.3.2. Competitive Scenario
      • 5.10.3.3. Regulatory framework
      • 5.10.3.4. Reimbursement scenario
      • 5.10.3.5. UAE market estimates and forecasts, 2018 - 2030
    • 5.10.4. Kuwait
      • 5.10.4.1. Key country dynamics
      • 5.10.4.2. Competitive Scenario
      • 5.10.4.3. Regulatory framework
      • 5.10.4.4. Reimbursement scenario
      • 5.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
    • 6.2.1. Innovators
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2022
    • 6.3.4. Elekta AB
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Huiheng Medical, Inc.
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. MASEP Medical Science Technology Development (Shenzhen) Co., Ltd.
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Akesis Inc.
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America Gamma Knife market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 4 U.S. Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 5 Canada Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 6 Europe Gamma Knife market, by region, 2018 - 2030 (USD Million)
  • Table 7 Europe Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 8 U.K. Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 9 Germany Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 10 France Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 11 Italy Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 12 Spain Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 13 Denmark Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 14 Sweden Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 15 Norway Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific Gamma Knife market, by region, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 18 Japan Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 19 China Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 20 India Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 21 Australia Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 22 Thailand Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 23 South Korea Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 24 Latin America Gamma Knife market, by region, 2018 - 2030 (USD Million)
  • Table 25 Latin America Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 26 Brazil Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 27 Mexico Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 28 Argentina Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa Gamma Knife market, by region, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 31 South Africa Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 33 UAE Gamma Knife market, by indication, 2018 - 2030 (USD Million)
  • Table 34 Kuwait Gamma Knife market, by indication, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Gamma Knife market: market outlook
  • Fig. 14 Gamma Knife market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Gamma Knife market driver impact
  • Fig. 18 Gamma Knife market restraint impact
  • Fig. 19 Gamma Knife market strategic initiatives analysis
  • Fig. 20 Gamma Knife market: Indication movement analysis
  • Fig. 21 Gamma Knife market: Indication outlook and key takeaways
  • Fig. 22 Malignant tumors market estimates and forecast, 2018 - 2030
  • Fig. 23 Benign tumors market estimates and forecast, 2018 - 2030
  • Fig. 24 Vascular disorders market estimates and forecast, 2018 - 2030
  • Fig. 25 Functional disorders therapy market estimates and forecast, 2018 - 2030
  • Fig. 26 Ocular market estimates and forecast, 2018 - 2030
  • Fig. 27 Global Gamma Knife market: Regional movement analysis
  • Fig. 28 Global Gamma Knife market: Regional outlook and key takeaways
  • Fig. 29 Global market shares and leading players
  • Fig. 30 North America market share and leading players
  • Fig. 31 Europe market share and leading players
  • Fig. 32 Asia Pacific market share and leading players
  • Fig. 33 Latin America market share and leading players
  • Fig. 34 Middle East & Africa market share and leading players
  • Fig. 35 North America: SWOT
  • Fig. 36 Europe SWOT
  • Fig. 37 Asia Pacific SWOT
  • Fig. 38 Latin America SWOT
  • Fig. 39 MEA SWOT
  • Fig. 40 North America, by country
  • Fig. 41 North America
  • Fig. 42 North America market estimates and forecast, 2018 - 2030
  • Fig. 43 U.S.
  • Fig. 44 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 45 Canada
  • Fig. 46 Canada market estimates and forecast, 2018 - 2030
  • Fig. 47 Europe
  • Fig. 48 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 49 U.K.
  • Fig. 50 U.K. market estimates and forecast, 2018 - 2030
  • Fig. 51 Germany
  • Fig. 52 Germany market estimates and forecast, 2018 - 2030
  • Fig. 53 France
  • Fig. 54 France market estimates and forecast, 2018 - 2030
  • Fig. 55 Italy
  • Fig. 56 Italy market estimates and forecast, 2018 - 2030
  • Fig. 57 Spain
  • Fig. 58 Spain market estimates and forecast, 2018 - 2030
  • Fig. 59 Denmark
  • Fig. 60 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 61 Sweden
  • Fig. 62 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 63 Norway
  • Fig. 64 Norway market estimates and forecast, 2018 - 2030
  • Fig. 65 Asia Pacific
  • Fig. 66 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 67 Japan
  • Fig. 68 Japan market estimates and forecast, 2018 - 2030
  • Fig. 69 China
  • Fig. 70 China market estimates and forecast, 2018 - 2030
  • Fig. 71 India
  • Fig. 72 India market estimates and forecast, 2018 - 2030
  • Fig. 73 Australia
  • Fig. 74 Australia market estimates and forecast, 2018 - 2030
  • Fig. 75 Thailand
  • Fig. 76 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 77 South Korea
  • Fig. 78 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 79 Latin America
  • Fig. 80 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 81 Brazil
  • Fig. 82 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 83 Mexico
  • Fig. 84 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 85 Argentina
  • Fig. 86 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 87 Middle East and Africa
  • Fig. 88 Middle East and Africa market estimates and forecast, 2018 - 2030
  • Fig. 89 Saudi Arabia
  • Fig. 90 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 91 South Africa
  • Fig. 92 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 93 UAE
  • Fig. 94 UAE market estimates and forecast, 2018 - 2030
  • Fig. 95 Kuwait
  • Fig. 96 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 97 Participant categorization - Gamma Knife market
  • Fig. 98 Market share of key market players - Gamma Knife market